The European Commission has granted conditional approval for Ipsen’s IQIRVO (elafibranor) for the treatment of primary biliary cholangitis in adults, marking the first new therapy for this condition to be approved in the EU in […]
Tag: DelveInsight Business Research
Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6% by 2030
The hormone replacement therapy market is witnessing substantial growth due to the rising occurrence of hormonal and targeted conditions such as menopause and osteoporosis, coupled with the growing elderly population, which is fueling demand for […]
Axial Spondyloarthritis Market – US to Have the Lion’s Share Among the 7MM
The axial spondyloarthritis market is experiencing robust growth due to increasing awareness and advancements in treatment options. Rising prevalence rates and a growing focus on personalized medicine are driving market expansion, with innovative therapies and […]
CEACAM5 Drugs Market Outlook: Rising Cancer Cases and Clinical Trials to Fuel Growth by 2034
The CEACAM5 drugs market is expected to grow significantly in the coming years. This is due to the increasing number of patients being diagnosed with cancer and the increasing number of CEACAM5 that are under […]
Expanding the Bispecific Antibody Market from CAR-Ts to Drive Follicular Lymphoma’s Future
The competition in follicular lymphoma is rapidly intensifying, with three CAR-T therapies and three bispecific antibodies now approved for relapsed or refractory patients. As both classes of treatments expand, the battle for dominance in this […]